======= FABP1 =======
== Gene Information ==
* **Official Symbol**: FABP1
* **Official Name**: fatty acid binding protein 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2168|2168]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P07148|P07148]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=FABP1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FABP1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/134650|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Plays a role in lipoprotein-mediated cholesterol uptake in hepatocytes (PubMed:25732850). Binds cholesterol (PubMed:25732850). Binds free fatty acids and their coenzyme A derivatives, bilirubin, and some other small molecules in the cytoplasm. May be involved in intracellular lipid transport (By similarity). {ECO:0000250|UniProtKB:P82289, ECO:0000269|PubMed:25732850}.
|Lipocalin|
|apical cortex|
|bile acid binding|
|positive regulation of fatty acid beta-oxidation|
|long-chain fatty acid transporter activity|
|positive regulation of fatty acid oxidation|
|regulation of fatty acid beta-oxidation|
|antioxidant activity|
|fatty acid binding|
|positive regulation of lipid catabolic process|
|triglyceride catabolic process|
|regulation of fatty acid oxidation|
|intestinal absorption|
|positive regulation of fatty acid metabolic process|
|neutral lipid catabolic process|
|acylglycerol catabolic process|
|peroxisomal matrix|
|glycerolipid catabolic process|
|regulation of lipid catabolic process|
|drug binding|
|long-chain fatty acid transport|
|cellular response to hydrogen peroxide|
|fatty acid transport|
|digestive system process|
|triglyceride metabolic process|
|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|
|regulation of fatty acid metabolic process|
|cellular oxidant detoxification|
|negative regulation of cysteine-type endopeptidase activity|
|acylglycerol metabolic process|
|neutral lipid metabolic process|
|cellular detoxification|
|phospholipid binding|
|digestion|
|cellular response to antibiotic|
|response to hydrogen peroxide|
|detoxification|
|cellular response to reactive oxygen species|
|monocarboxylic acid transport|
|positive regulation of small molecule metabolic process|
|positive regulation of lipid metabolic process|
|regulation of cellular ketone metabolic process|
|cellular response to hypoxia|
|response to reactive oxygen species|
|cellular lipid catabolic process|
|cellular response to decreased oxygen levels|
|cellular response to toxic substance|
|cellular response to oxygen levels|
|regulation of cysteine-type endopeptidase activity involved in apoptotic process|
|cellular response to oxidative stress|
|regulation of cysteine-type endopeptidase activity|
|negative regulation of endopeptidase activity|
|negative regulation of peptidase activity|
|organic acid transport|
|carboxylic acid transport|
|lipid transport|
|lipid catabolic process|
|response to antibiotic|
|lipid localization|
|response to hypoxia|
|negative regulation of proteolysis|
|response to decreased oxygen levels|
|positive regulation of cellular catabolic process|
|glycerolipid metabolic process|
|response to oxygen levels|
|response to oxidative stress|
|chromatin binding|
|regulation of lipid metabolic process|
|cellular response to drug|
|regulation of endopeptidase activity|
|regulation of small molecule metabolic process|
|positive regulation of catabolic process|
|regulation of peptidase activity|
|negative regulation of hydrolase activity|
|organic anion transport|
|response to toxic substance|
|response to inorganic substance|
|anion transport|
|protein-containing complex|
|regulation of proteolysis|
|positive regulation of hydrolase activity|
|negative regulation of catalytic activity|
|regulation of cellular catabolic process|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|cellular lipid metabolic process|
|regulation of catabolic process|
|negative regulation of cell death|
|response to drug|
|negative regulation of cellular protein metabolic process|
|cellular response to oxygen-containing compound|
|negative regulation of protein metabolic process|
|negative regulation of molecular function|
|response to abiotic stimulus|
|lipid metabolic process|
|regulation of hydrolase activity|
|ion transport|
|positive regulation of catalytic activity|
|regulation of apoptotic process|
|response to oxygen-containing compound|
|regulation of programmed cell death|
|regulation of cell death|
|cellular response to stress|
|organic substance catabolic process|
|positive regulation of molecular function|
|cellular catabolic process|
|system process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.71|
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.8|
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|1.83|
|[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|2.02|
|[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|2.7|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13446
* **Expression level (log2 read counts)**: -7.68
{{:chemogenomics:nalm6 dist.png?nolink |}}